During the past decade, Iwate Medical University Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 29 clinical trials were completed, i.e. on average, 61.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 14 clinical trials were completed. i.e. 82.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iwate Medical University Hospital" #1 sponsor was "Pfizer" with 11 trials, followed by "Janssen Research & Development, LLC" with 9 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Iwate Medical University" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iwate Medical University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator and "Human Genome Center, Institute of Medical Science, University of Tokyo" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Iwate Medical University Hospital" are "Ulcerative Colitis" (7 trials), "Multiple Myeloma" (4 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials) and "Migraine" (3 trials). Many other conditions were trialed in "Iwate Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Iwate Medical University Hospital" are "Drug" (64 trials), "Other" (14 trials), "Biological" (8 trials), "Procedure" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Paclitaxel" (9 trials), "Carboplatin" (8 trials), "Laboratory Biomarker Analysis" (7 trials) and "Quality-of-Life Assessment" (6 trials). Other intervention names were less common.

The vast majority of trials in "Iwate Medical University Hospital" are 62 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Iwate Medical University Hospital". undefined are not yet recruiting, 18 are recruiting, 16 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 36 completed trials in Iwate Medical University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Iwate Medical University Hospital, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".

Iwate Medical University Hospital has several departments that took part in Clinical trials: "Iwate Med Univ School of Med; Surgery" - 4 trials